๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Second-line treatment paradigms for diffuse large B-cell lymphomas

โœ Scribed by Catherine Thieblemont; Christian Gisselbrecht

Book ID
107546700
Publisher
Current Science Inc.
Year
2009
Tongue
English
Weight
329 KB
Volume
11
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of diffuse large B-cell lympho
Treatment of diffuse large B-cell lymphomas
โœ C. Zwick; N. Murawski; Michael Pfreundschuh ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 302 KB
International prognostic index-based out
International prognostic index-based outcomes for diffuse large B-cell lymphomas
โœ Richard B. Wilder; Maria A. Rodriguez; L. Jeffrey Medeiros; Susan L. Tucker; Chu ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB

## Abstract ## BACKGROUND We present the results of doxorubicinโ€based chemotherapy with or without involvedโ€field radiotherapy for patients with diffuse large Bโ€cell lymphoma (DLBCL) according to the international prognostic index (IPI). ## METHODS From September 1988 through December 1996, 294

Prognostic models for diffuse large b-ce
Prognostic models for diffuse large b-cell lymphoma
โœ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

Prognosis of DLCL patients is variable and associated with well-deยฎned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation